PROB: Probi AB (publ) - Summary | Jitta

Probi AB (publ)

SWE:PROB

Notice
Stock data is unavailable or the company’s delisted.
Price
kr348.00
Loss Chance
51.0%
3.55JITTA SCORE
> 1,000%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (21)
Recent Business Performance (51)
Financial Strength (83)
Return to Shareholders (11)
Competitive Advantage (36)
Jitta Signs
Debt LevelLow Long Term Debt
Revenue and EarningRevenue decline from 2020-2023
Operating MarginDeclined
Recent Business PerformanceEarning decline 43.66% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.55
> 1,000%
2.88
97.44%
2.88
97.44%
4.03
10.43%
1.32
100.00%
1.89
100.00%
COMPANY DESCRIPTION
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children’s, women’s, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, chilled diary and plant based products, frozen desserts and ice-cream, powder formulas, and recovery drinks. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) operates as a subsidiary of Symrise AG.